Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Tayfun Güngör

University of Zurich

Switzerland

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Internal Medicine

20%

Immunology

40%

Graft-versus-host Disease

50%

Transplantation

50%

Pediatric Hematology

40%

Medical Science

20%

Stem Cell Transplantation

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles21

Comparable outcomes after busulfan- or treosulfan-based conditioning for allo-HSCT in children with ALL: results of FORUM

Article Link

Year:

2025

Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT study

Article Link

Year:

2025

Managing High‐Risk PTPN11‐Mutated Juvenile Myelomonocytic Leukemia in a Patient with SETBP1 Mosaicism

Article Link

Year:

2025

HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective study

Article Link

Year:

2025

Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature.

Article Link

Year:

2025

High Amphiregulin Expression in Intestinal Biopsies of Pediatric Patients with Severe Acute Graft-Versus-Host Disease

Article Link

Year:

2025

Mold infections in chronic granulomatous disease patients—what comes to the rescue?

Article Link

Year:

2025

Mulch pneumonitis in chronic granulomatous disease: More than just a fungal infection

Article Link

Year:

2024

Outcomes of patients undergoing allogeneic haematopoietic stem cell transplantation for congenital amegakaryocytic thrombocytopenia; a study on behalf of the PDWP of the EBMT

Article Link

Year:

2024

Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunity

Article Link

Year:

2024

Population Pharmacokinetic Modeling for Twice-Daily Intravenous Busulfan in a Large Cohort of Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation—A 10-Year Single-Center Experience

Article Link

Year:

2023

Correction: ABO incompatibile graft management in pediatric transplantation (Bone Marrow Transplantation, (2021), 56, 1, (84-90), 10.1038/s41409-020-0981-7)

Article Link

Year:

2021

Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantation

Article Link

Year:

2021

Multisystem Inflammation and Susceptibility to Viral infections in Human ZNFX1 Deficiency

Article Link

Year:

2021

Correction: Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT).

Article Link

Year:

2020

Hematopoietic cell transplantation in chronic granulomatous disease: a study of 712 children and adults.

Article Link

Year:

2020

Artificial thymic organoids represent a reliable tool to study T-cell differentiation in patients with severe T-cell lymphopenia.

Article Link

Year:

2020

Cellular Therapies in Chronic Granulomatous Disease.

Article Link

Year:

2020

Children with WAS: prefer early transplant!

Article Link

Year:

2020

Correction: High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation.

Article Link

Year:

2020

Correction: Supportive care during pediatric hematopoietic stem cell transplantation: beyond infectious diseases. A report from workshops on supportive care of the Pediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT).

Article Link

Year:

2020

Collaborators22

Dominic Bräm

University Children’s Hospital Basel

SWITZERLAND

Michael Huber

Head Diagnostics and Development

University of Zurich

SWITZERLAND

Stéphane Buhler

University of Geneva

SWITZERLAND

Sebastian Hiller

University of Basel

SWITZERLAND

Quentin RILLER

Imagine Institute for Genetic Diseases

FRANCE

marc ansari

Head of the Cansearch Research platform for pediatric oncology and hematology, Faculty of Medicine

Université de Genève

SWITZERLAND

Jana Pachlopnik Schmid

University of Zurich

SWITZERLAND

Henrik Sengelov

professor

University of Copenhagen

DENMARK

Stefano Vavassori

Chief Operating Officer

metaLead Therapeutics AG

SWITZERLAND

Claire Booth

Senior Clinical Lecturer

University College London Institute of Child Health

UNITED KINGDOM

Andrew James Martins

Yale University

UNITED STATES

KRZYSZTOF KALWAK

MD, PhD, Prof.

Wroclaw Medical University

POLAND

Mathias M Hauri-Hohl

University Children's Hospital Zurich

SWITZERLAND

Jean Villard

SWITZERLAND

Barbara Brotschi

University Children's Hospital Zurich

SWITZERLAND

Su Han Lum

Leiden University Medical Center

NETHERLANDS

Dominic Lenz

GERMANY

Kerry Dobbs

Research Scientist and Head of Laboratory Operations

UNITED STATES

Michael Gabbett

Queensland University of Technology

AUSTRALIA

Tamara Diesch-Furlanetto

University Children’s Hospital Basel

SWITZERLAND

Karin Mellgren

Adj Professor

University of Gothenburg

SWEDEN

Stefanie D. Krämer

Adjunct Professor

ETH Zürich

SWITZERLAND

How do I reach out?

Meet Kite AI